BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30910004
Number of visits today
512
Number of downloads
13442185
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Roostaeyan O, Kivelevitch D, Menter A. A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis. Immunotherapy 2017;9:963-78. [PMID: 28879789 DOI: 10.2217/imt-2017-0077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 D’adamio S, Silvaggio D, Lombardo P, Bianchi L, Talamonti M, Galluzzo M. The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis. Expert Opinion on Drug Safety 2019;18:1031-41. [DOI: 10.1080/14740338.2019.1663168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pușcaș AD, Cătană A, Pușcaș C, Roman II, Vornicescu C, Șomlea M, Orăsan RI. Psoriasis: Association of interleukin-17 gene polymorphisms with severity and response to treatment. Exp Ther Med 2019;18:875-80. [PMID: 31384317 DOI: 10.3892/etm.2019.7624] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Ouyang S, Liu C, Xiao J, Chen X, Lui AC, Li X. Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases. JCI Insight 2020;5:132836. [PMID: 32051346 DOI: 10.1172/jci.insight.132836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Saavedra MA, Romo-Rodríguez R, Gutiérrez-Ureña SR, Miranda-Hernández D, Hernández-Cruz LI, Jara LJ. Targeted drugs in spondyloarthritis during pregnancy and lactation. Pharmacol Res 2018;136:21-8. [PMID: 30125669 DOI: 10.1016/j.phrs.2018.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345